HAIC (Hepatic Artery Infusion Chemotherapy ，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma Interventions: Drug: Donafenib ； Sintilimab； HAIC Sponsors: Wuhan Union Hospital, China Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials